LLY compared with LYEL: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

LYELLyell Immunopharma, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

LYELLyell Immunopharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only LYEL 11

—City of Hope Comprehensive Cancer Centerunlistedsupplier

—Dana Farber Cancer Instituteunlistedsupplier

—Innovative Cellular Therapeutics Holdings Limited and Innovative Cellular Therapeutics, Inc. (together, ICT)unlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

—Miltenyi CliniMACS PRODIGY ®unlistedsupplier

7 more · LYEL chain ›

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

LYELLyell Immunopharma, Inc.

14.85▼−1.03%· post 14.85

ClosedNov 6 '26

Mkt cap$365.3MRevenue$3,000Q3 FY26Revenue$36,000FY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

LYELLyell Immunopharma, Inc.

1,360.90▼−0.28%post 1,358.90

Price

14.85▼−1.03%post 14.85

$1.2T

Mkt cap

$365.3M

Q3 FY26$24.4B

Revenue

$3,000Q3 FY26

FY25$65.2B

Revenue

$36,000FY25

LLY1,360.90▼−0.28%vsLYEL14.85▼−1.03%ClosedNov 6 '26